Tandem Diabetes Care (TNDM) Other Working Capital Changes (2013 - 2026)

Tandem Diabetes Care's Other Working Capital Changes history runs 14 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• Quarterly Other Working Capital Changes rose 213.03% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 96.27% YoY) and the FY2025 annual result came in at -$4.8 million, up 86.22% from the prior year.
• Other Working Capital Changes was $1.8 million for Q1 2026 at Tandem Diabetes Care, up from -$686000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $19.0 million in Q1 2026 and bottomed at -$3.1 million in Q4 2025.
• A 5-year average of $2.5 million and a median of $1.4 million in 2022 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes soared 1395.08% — and 2024, when it plunged 1961.99%.
• Tandem Diabetes Care's Other Working Capital Changes stood at -$23.3 million in 2022, then soared by 108.37% to $2.0 million in 2023, then plunged by 1961.99% to -$36.3 million in 2024, then jumped by 98.11% to -$686000.0 in 2025, then jumped by 362.97% to $1.8 million in 2026.
• Business Quant data shows TNDM's Other Working Capital Changes at $1.8 million in Q1 2026, -$686000.0 in Q4 2025, and -$12.5 million in Q3 2025.